Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
NCT04005638 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-03-26
Summary
The Internal Medicine Department of Haut-Lévêque Hospital (Pr E LAZARO, Pr JL PELLEGRIN, Pr JF VIALLARD) was accredited in 2017 by the Ministry of Health as a Constitutive Reference Center for Autoimmune Cytopenia. The investigators wish to launch new research projects in autoimmune cytopenia and propose a translational and fundamental research based on collaboration between the clinical department, the biological resource center and the CNRS and INSERM research units ("Bedside to the Bench Strategy"). Thus, in the perspective of future research work, it seems imperative to set up a biological bank for the patients followed in our Reference Center.
Conditions
- Immune Thrombocytopenia
- Autoimmune Hemolytic Anemia
- Autoimmune Neutropenia
Interventions
- BIOLOGICAL
-
blood sample
45 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation
- BIOLOGICAL
-
urine sample
12 ml
Sponsors & Collaborators
-
Ministry for Health and Solidarity, France
collaborator OTHER_GOV -
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Jean-François VIALLARD, Prof · University Hospital, Bordeaux
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-02
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- France
Study Locations
More Related Trials
-
Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy
NCT06476535 ·Status: ACTIVE_NOT_RECRUITING
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
NCT06979765 ·Status: RECRUITING ·Phase: NA
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)
NCT02287649 ·Status: COMPLETED ·Phase: NA
-
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
NCT04800458 ·Status: RECRUITING ·Phase: NA
-
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT01101295 ·Status: UNKNOWN
-
Collection of Blood From Patients With Pancytopenia
NCT00001214 ·Status: COMPLETED
-
Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)
NCT02821572 ·Status: RECRUITING
-
Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
NCT00225875 ·Status: TERMINATED ·Phase: PHASE2
-
PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy
NCT05676697 ·Status: TERMINATED ·Phase: PHASE1
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring
NCT03225079 ·Status: TERMINATED
-
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
NCT07059000 ·Status: RECRUITING ·Phase: PHASE3
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy
NCT07091370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
French Adult Primary Immune Thrombocytopenia
NCT03429660 ·Status: UNKNOWN
-
Biologic Characterization of Patients With ITP
NCT05694325 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia
NCT05232149 ·Status: UNKNOWN ·Phase: PHASE2
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)
NCT05419648 ·Status: COMPLETED
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
OM336 in Autoimmune Cytopenias
NCT07083960 ·Status: RECRUITING ·Phase: PHASE1
-
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
NCT02689986 ·Status: COMPLETED ·Phase: PHASE2